Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amit Kalra

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Bone Marrow Transplantation|October 7, 2021
Mild clinical course of SARS-coronavirus-2 infection early posttransplant in patients with adoptively transferred antibody responseJan Storek, Jamil N Kanji, May Choi, et al.
Cytotherapy|June 30, 2019
High incidence of hematologic malignancy relapse after allogeneic transplantation in patients with low Epstein-Barr virus-specific T-cell countsMehul Gupta, Sunand Kannappan, Amit Kalra, et al.
Transplantation and Cellular Therapy|October 23, 2022
Rituximab Toxicity after Preemptive or Therapeutic Administration for Post-Transplant Lymphoproliferative DisorderMegan Kinzel, Amit Kalra, Rutvij A Khanolkar, et al.
Clinical & Experimental Metastasis|May 7, 2013
Efficacy and mechanism of action of Deguelin in suppressing metastasis of 4T1 cellsRajeshwari R Mehta, Harshadadevi Katta, Amit Kalra, et al.
International Journal of Molecular Sciences|December 23, 2022
Donor Genetic Predisposition to High Interleukin-10 Production Appears Protective against Acute Graft-Versus-Host DiseaseGaurav Tripathi, Rutvij A Khanolkar, Rehan M Faridi, et al.
Clinical Transplantation|November 9, 2017
Risk factors for post-transplant lymphoproliferative disorder after Thymoglobulin-conditioned hematopoietic cell transplantationAmit Kalra, Cameron Roessner, Jennifer Jupp, et al.
Cytotherapy|March 28, 2018
Epstein-barr virus DNAemia monitoring for the management of post-transplant lymphoproliferative disorderAmit Kalra, Cameron Roessner, Jennifer Jupp, et al.
Gastrointestinal Endoscopy|August 25, 2009
Minimally invasive measurement of esophageal variceal pressure and wall tension (with video)Anil K Vegesna, Chan Y Chung, Anurag Bajaj, et al.
Cytotherapy|August 10, 2021
A biomarker-guided, prospective, phase 2 trial of pre-emptive graft-versus-host disease therapy using anti-thymocyte globulinRutvij A Khanolkar, Amit Kalra, Megan Kinzel, et al.
Clinical Transplantation|June 24, 2020
Hematopoietic cell transplant outcomes after myeloablative conditioning with fludarabine, busulfan, low-dose total body irradiation, and rabbit antithymocyte globulinSamar Ousia, Amit Kalra, Tyler S Williamson, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Bone Marrow Transplantation|October 7, 2021
Mild clinical course of SARS-coronavirus-2 infection early posttransplant in patients with adoptively transferred antibody responseJan Storek, Jamil N Kanji, May Choi, et al.
Cytotherapy|June 30, 2019
High incidence of hematologic malignancy relapse after allogeneic transplantation in patients with low Epstein-Barr virus-specific T-cell countsMehul Gupta, Sunand Kannappan, Amit Kalra, et al.
Transplantation and Cellular Therapy|October 23, 2022
Rituximab Toxicity after Preemptive or Therapeutic Administration for Post-Transplant Lymphoproliferative DisorderMegan Kinzel, Amit Kalra, Rutvij A Khanolkar, et al.
Clinical & Experimental Metastasis|May 7, 2013
Efficacy and mechanism of action of Deguelin in suppressing metastasis of 4T1 cellsRajeshwari R Mehta, Harshadadevi Katta, Amit Kalra, et al.
International Journal of Molecular Sciences|December 23, 2022
Donor Genetic Predisposition to High Interleukin-10 Production Appears Protective against Acute Graft-Versus-Host DiseaseGaurav Tripathi, Rutvij A Khanolkar, Rehan M Faridi, et al.
Clinical Transplantation|November 9, 2017
Risk factors for post-transplant lymphoproliferative disorder after Thymoglobulin-conditioned hematopoietic cell transplantationAmit Kalra, Cameron Roessner, Jennifer Jupp, et al.
Cytotherapy|March 28, 2018
Epstein-barr virus DNAemia monitoring for the management of post-transplant lymphoproliferative disorderAmit Kalra, Cameron Roessner, Jennifer Jupp, et al.
Gastrointestinal Endoscopy|August 25, 2009
Minimally invasive measurement of esophageal variceal pressure and wall tension (with video)Anil K Vegesna, Chan Y Chung, Anurag Bajaj, et al.
Cytotherapy|August 10, 2021
A biomarker-guided, prospective, phase 2 trial of pre-emptive graft-versus-host disease therapy using anti-thymocyte globulinRutvij A Khanolkar, Amit Kalra, Megan Kinzel, et al.
Clinical Transplantation|June 24, 2020
Hematopoietic cell transplant outcomes after myeloablative conditioning with fludarabine, busulfan, low-dose total body irradiation, and rabbit antithymocyte globulinSamar Ousia, Amit Kalra, Tyler S Williamson, et al.
Pageof 4